Renaissance Technologies’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,465
Closed -$733K 3670
2024
Q3
$733K Buy
+27,465
New +$733K ﹤0.01% 2610
2024
Q2
Sell
-45,400
Closed -$828K 3624
2024
Q1
$828K Sell
45,400
-19,300
-30% -$352K ﹤0.01% 2597
2023
Q4
$708K Sell
64,700
-86,300
-57% -$944K ﹤0.01% 2594
2023
Q3
$865K Buy
151,000
+43,500
+40% +$249K ﹤0.01% 2401
2023
Q2
$833K Buy
107,500
+10,700
+11% +$82.9K ﹤0.01% 2577
2023
Q1
$646K Buy
96,800
+19,200
+25% +$128K ﹤0.01% 2735
2022
Q4
$694K Buy
77,600
+19,300
+33% +$173K ﹤0.01% 2747
2022
Q3
$574K Buy
58,300
+25,700
+79% +$253K ﹤0.01% 2846
2022
Q2
$259K Buy
+32,600
New +$259K ﹤0.01% 3530